ROCURONIUM BROMIDE

Launch

rocuronium bromide

NDAINTRAVENOUSSOLUTION
Approved
Jun 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT00124735Phase 3Completed

A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)

Started Oct 2004
149 enrolled
Anesthesia
NCT00535743Phase 2Completed

Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)

Started Mar 2004
174 enrolled
Anesthesia, General